Submission + - Computer-designed enzymes may help alleviate celiac disease (acs.org)
This development is only made possible by computational cataloguing and modeling of enzymes. The resulting enzyme, given the name KumaMax, shows eventual promise as an oral enzyme therapy for celiac disease taken prior to the ingestion of gluten-containing foods. It is attractive as a non-invasive oral therapeutic which can break down over 95% of the immunogenic peptide under physiologically relevant conditions.